AU2003225479A1 - Reporter-selectable hepatitis c virus replicon - Google Patents

Reporter-selectable hepatitis c virus replicon

Info

Publication number: AU2003225479A1
Authority: AU; Australia
Prior art keywords: reporter; hepatitis; selectable; virus replicon; replicon
Prior art date: 2002-04-26
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003225479A

Inventor

Rohit Duggal

Amy Karen Patick

Jie Zhang

Weidong Zhao

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Pfizer Inc

Original Assignee

Pfizer Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-04-26

Filing date

2003-04-22

Publication date

2003-11-10

2003-04-22 Application filed by Pfizer Inc filed Critical Pfizer Inc

2003-11-10 Publication of AU2003225479A1 publication Critical patent/AU2003225479A1/en

Status Abandoned legal-status Critical Current

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
- C12N2770/32122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
- C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES

AU2003225479A 2002-04-26 2003-04-22 Reporter-selectable hepatitis c virus replicon Abandoned AU2003225479A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US37566702P	2002-04-26	2002-04-26
US60/375,667		2002-04-26
PCT/IB2003/001687 WO2003091439A1 (en)	2002-04-26	2003-04-22	Reporter-selectable hepatitis c virus replicon

Publications (1)

Publication Number	Publication Date
AU2003225479A1 true AU2003225479A1 (en)	2003-11-10

Family

ID=29270683

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003225479A Abandoned AU2003225479A1 (en)	2002-04-26	2003-04-22	Reporter-selectable hepatitis c virus replicon

Country Status (6)

Country	Link
EP (1)	EP1499727A1 (en)
JP (1)	JP2005523705A (en)
AU (1)	AU2003225479A1 (en)
CA (1)	CA2483513A1 (en)
MX (1)	MXPA04010548A (en)
WO (1)	WO2003091439A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2007011777A2 (en) *	2005-07-18	2007-01-25	Novartis Ag	Small animal model for hcv replication
DK4066819T3 (en) *	2010-08-31	2023-04-24	Glaxosmithkline Biologicals Sa	Small liposomes for delivery of RNA encoding immunogen
CN107475294B (en) *	2017-08-16	2020-10-09	四川农业大学	Preparation method of duck tembusu report virus carrying renilla luciferase, product and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5292658A (en) *	1989-12-29	1994-03-08	University Of Georgia Research Foundation, Inc. Boyd Graduate Studies Research Center	Cloning and expressions of Renilla luciferase
DE19915178A1 (en) *	1999-04-03	2000-10-05	Univ Mainz Johannes Gutenberg	Hepatitis C virus cell culture system

2003
- 2003-04-22 MX MXPA04010548A patent/MXPA04010548A/en not_active Application Discontinuation
- 2003-04-22 CA CA002483513A patent/CA2483513A1/en not_active Abandoned
- 2003-04-22 EP EP03747188A patent/EP1499727A1/en not_active Withdrawn
- 2003-04-22 AU AU2003225479A patent/AU2003225479A1/en not_active Abandoned
- 2003-04-22 WO PCT/IB2003/001687 patent/WO2003091439A1/en not_active Application Discontinuation
- 2003-04-22 JP JP2003587967A patent/JP2005523705A/en active Pending

Also Published As

Publication number	Publication date
MXPA04010548A (en)	2005-01-25
EP1499727A1 (en)	2005-01-26
WO2003091439A1 (en)	2003-11-06
JP2005523705A (en)	2005-08-11
CA2483513A1 (en)	2003-11-06

Legal Events

Date	Code	Title	Description
2005-01-13	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase

Publication	Publication Date	Title
HK1070287A1 (en)	2005-06-17	Hepatitis c virus inhibitors
PL371007A1 (en)	2005-06-13	Macrocyclic peptides active against the hepatitis c virus
EP1684787A4 (en)	2009-08-05	Hepatitis c virus inhibitors
EP1684745A4 (en)	2008-11-19	Hepatitis c virus inhibitors
IL174403A0 (en)	2006-08-01	Macrocyclic peptides active against the hepatitis c virus
AU2003238456A1 (en)	2003-09-02	Viral vector
AU2003215209A1 (en)	2004-06-03	Syringe
AU2003215806A1 (en)	2003-12-12	Disinfectant with activity against hepatitis b virus
AU2003206862A1 (en)	2003-09-02	Hepatitis b vaccines
AU2003259457A1 (en)	2004-04-30	Auto-destructible syringe
AU2003301850A1 (en)	2004-06-07	Hiv vaccine
AU2003294757A1 (en)	2004-06-23	Formulations useful against hepatitis c virus infections
AU2003301865A1 (en)	2004-06-07	Epitopes of hepatitis c virus
AU2003230790A1 (en)	2003-10-20	Hepatitis c virus sub-genomic replicons
AU2003225479A1 (en)	2003-11-10	Reporter-selectable hepatitis c virus replicon
AU2003227026A1 (en)	2003-09-16	An infectious bursal disease virus variant
AU2003255727A1 (en)	2004-02-16	Syringes
AU2003272974A1 (en)	2004-05-04	Anti-influenza virus agent
AU2003256404A1 (en)	2004-02-25	Hepatitis c virus assays
AU2003293807A1 (en)	2004-07-22	Mhc class i restricted t-cell stimulating peptides from hepatitis b virus
AU2003221569A1 (en)	2003-10-20	Cd4+ t-lymphocyte-specific hepatitis c virus epitopes
AU2003214299A1 (en)	2003-07-24	Hiv-1 virus tat-protein mutants
AU2003272147A1 (en)	2004-05-04	Expressional enhancers from viruses
AU2003263028A1 (en)	2003-11-10	Mouse hepatitis virus detection
AU2003233751A1 (en)	2003-10-27	Scaffolding